Lyons Wealth Management LLC. Decreases Holdings in CVS Health (CVS)

Cornelia Mascio
Aprile 20, 2018

Checchi Capital Advisers LLC now owns 9,063 shares of the pharmacy operator's stock worth $657,000 after buying an additional 1,150 shares during the period. Kanawha Mgmt Limited Co invested in 39,632 shares. The stock increased 0.80% or $0.23 during the last trading session, reaching $28.93. About 754,341 shares traded. Neogen Corporation (NASDAQ:NEOG) has risen 34.54% since April 19, 2017 and is uptrending. It has underperformed by 4.81% the S&P500.

Oak Associates Ltd decreased its stake in Cvs Health Corporation (CVS) by 90.87% based on its latest 2017Q4 regulatory filing with the SEC. The institutional investor owned 11,307 shares of the pharmacy operator's stock after selling 725 shares during the quarter.

Mark Sheptoff Financial Planning Llc, which manages about $218.89M and $153.76M US Long portfolio, upped its stake in Boise Cascade Co Del (NYSE:BCC) by 8,301 shares to 18,351 shares, valued at $732,000 in 2017Q4, according to the filing. Hamel Associates Inc who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $66.95B market cap company. PGGM Investments now owns 1,270,407 shares of the pharmacy operator's stock valued at $103,309,000 after acquiring an additional 172,368 shares during the last quarter. About 3.28M shares traded. Since April 20, 2017 CVS has declined 22.81% and is downtrending. It has underperformed by 34.36% the S&P500.

Investors sentiment decreased to 0.72 in Q4 2017. It has change of 0.16, from 2017Q3's 0.88.

Investors and Traders continue to monitor technical levels of shares of CVS Health Corporation (CVS). 134 funds bought holdings and 380 increased holdings. The pharmacy operator reported $1.92 earnings per share for the quarter, beating analysts' consensus estimates of $1.88 by $0.04. Glovista Investments LLC now owns 6,149 shares of the pharmacy operator's stock worth $495,000 after purchasing an additional 100 shares in the last quarter. Kidder Stephen W has 95,620 shares. Caprock Gp Inc Inc reported 0.2% stake.

Lyons Wealth Management LLC. trimmed its position in shares of CVS Health (NYSE:CVS) by 6.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. First Manhattan invested 0.53% in CVS Health Corporation (NYSE:CVS).

CVS Health Corporation (CVS) stock price distance from twenty day simple moving average surged at 5.56% while its distance from fifty day simple moving average declined -0.01% along with -9.91% below distance from two hundred simple moving averages. Sumitomo Life Ins holds 23,071 shs or 0.21% of its capital. South State has 0.53% invested in CVS Health Corporation (NYSE:CVS) for 67,125 shares. Insight 2811 stated it has 0.51% of its portfolio in CVS Health Corporation (NYSE:CVS). Nomura Asset Mngmt Commerce Limited invested in 459,436 shs or 0.39% of the stock. Chilton Invest Co Ltd Co invested 0.01% in CVS Health Corporation (NYSE:CVS). Middleton And Communications Ma owns 29,755 shares for 0.36% of their portfolio. Rwc Asset Mngmt Llp owns 126,975 shares for 0.49% of their portfolio. After $1.92 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts -27.08% negative EPS growth. They expect $1.40 earnings per share, up 19.66 % or $0.23 from last year's $1.17 per share. This could hit $1.42 billion profit for CVS assuming the current $1.40 EPS will become reality. Argyle Mgmt holds 1.05% of its portfolio in CVS Health Corporation (NYSE:CVS) for 38,560 shares. Finally, ValuEngine cut shares of CVS Health from a "buy" rating to a "hold" rating in a research note on Friday, February 2nd. The positive are 71%. Hannover Ruckversich had 3 analyst reports since July 24, 2015 according to SRatingsIntel.

The company also recently declared a quarterly dividend, which will be paid on Monday, May 1st.

COPYRIGHT VIOLATION WARNING: "CVS Health (NYSE:CVS) Shares Sold by Moreno Evelyn V" was reported by and is the property of of Finally, Royal Bank of Canada set a $89.00 price target on CVS Health and gave the company a "buy" rating in a research note on Thursday, February 8th. The firm earned "Buy" rating on Wednesday, April 11 by Bank of America. As per Monday, December 4, the company rating was maintained by Needham. Livforsakringsbolaget Skandia Omsesidigt boosted its holdings in CVS Health by 17.9% in the 4th quarter. On Tuesday, November 7 Leerink Swann maintained CVS Health Corporation (NYSE:CVS) rating. On Thursday, January 4 Raymond James upgraded CVS Health Corporation (NYSE:CVS) to "Buy" rating. As per Monday, January 8, the company rating was maintained by Leerink Swann.

Since February 16, 2018, it had 0 insider purchases, and 1 insider sale for $1.42 million activity. (NYSE:MRK) by 47,368 shares in the quarter, for a total of 143,745 shares, and has risen its stake in Ishares Tr Nasdaq Bio Fd (IBB). Its up 0.04, from 1.13 in 2017Q3.

In other news, EVP Helena Foulkes sold 19,965 shares of the stock in a transaction dated Friday, February 16th. 105 funds opened positions while 305 raised stakes. Cerebellum GP LLC bought a new position in shares of CVS Health in the fourth quarter worth about $130,000. Barclays Public Ltd Company reported 2.30M shares or 0.14% of all its holdings. Advisor Prtnrs Ltd Liability Corporation invested in 25,766 shares. Cacti Asset Management Llc who had been investing in Mastercard Inc. Cl A. Bright Rock Cap Management Lc invested in 2.18% or 111,000 shares. (NASDAQ:BIIB) for 920 shares. Usca Ria Ltd Company invested in 70,262 shares. (NASDAQ:BIIB). Sivik Global Healthcare Ltd Co stated it has 2.36% of its portfolio in Biogen Inc. Mark Sheptoff Fincl Planning Limited Liability Company reported 35,358 shares.

Since October 31, 2017, it had 0 buys, and 12 insider sales for $5.97 million activity.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE